|
|
Supernus Pharmaceuticals inc (SUPN) |
|
|
|
Supernus Pharmaceuticals Inc 's Yearly EPS from Cont. Operations Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
Annual EPS from Cont. Operations Annual Growth Rates Y/Y▼
|
SUPN Annual EPS from Cont. Operations Growth |
2022
|
2021
|
2020
|
2019
|
2018
|
Y / Y Annual EPS from Cont. Operations Change |
11.88 % |
-58.09 % |
11.57 % |
1.41 % |
88.5 % |
Annual EPS from Cont. Operations (in $) |
$1.13 |
$1.01 |
$2.41 |
$2.16 |
$2.13 |
Annual EPS from Cont. Operations Growth
Comment |
Supernus Pharmaceuticals Inc 's Annual EPS from Cont. Operations for the fiscal year ended 2022, grew by 11.88% to $1.13, from $1.01 achieved a year ago. Supernus Pharmaceuticals Inc 's growrh rate for EPS from Cont. Operations improved from -58.09 % decline in the fiscal year 2021.
Supernus Pharmaceuticals Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2022 Annual EPS from Cont. Operations within Healthcare Sector | Y/Y EPS from Cont. Operations Growth % | 2022 Annual EPS from Cont. Operations | Sonida Senior Living Inc | | | |